Cellectis (CLLS) Total Current Liabilities (2014 - 2026)

Cellectis (CLLS) recorded quarterly Total Current Liabilities of $134.5 million in Q1 2026, down 7.72% quarter-over-quarter from $145.8 million in Q4 2025, and down 17.27% on a YoY basis from $162.6 million in Q1 2025.

Cellectis (CLLS) Total Current Liabilities (2014 - 2026) Analysis & Trends

Cellectis' Total Current Liabilities history runs 13 years deep, the most recent figure standing at $134.5 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 17.27% year-over-year to $134.5 million; the TTM figure through Mar 2026 stood at $134.5 million (down 17.27% YoY), while the FY2025 annual figure was $145.8 million, down 12.34% from the prior year.
  • Total Current Liabilities was $134.5 million for Q1 2026 at Cellectis, down from $145.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $167.4 million in Q2 2025 to a low of $42.0 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $111.9 million across 5 years, with a median of $145.8 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities dropped 23.94% in 2023, then jumped 279.65% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $48.1 million in 2022, then soared by 222.34% to $155.1 million in 2023, then gained by 7.17% to $166.3 million in 2024, then decreased by 12.34% to $145.8 million in 2025, then slipped by 7.72% to $134.5 million in 2026.
  • The last three Total Current Liabilities figures came in at $134.5 million (Q1 2026), $145.8 million (Q4 2025), and $148.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 134.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 134.50 Mn
Dec 31, 2025 145.75 Mn
Sep 30, 2025 148.58 Mn
Jun 30, 2025 167.43 Mn
Mar 31, 2025 162.57 Mn
Dec 31, 2024 166.27 Mn
Sep 30, 2024 165.65 Mn
Jun 30, 2024 159.63 Mn
Mar 31, 2024 158.45 Mn
Dec 31, 2023 155.14 Mn
Sep 30, 2023 43.95 Mn
Jun 30, 2023 42.05 Mn
Mar 31, 2023 43.14 Mn
Dec 31, 2022 48.13 Mn
Sep 30, 2022 53.03 Mn
Jun 30, 2022 55.28 Mn
Mar 31, 2022 52.34 Mn
Dec 31, 2021 49.35 Mn
Sep 30, 2021 49.60 Mn
Jun 30, 2021 51.45 Mn